type here...

CATEGORIES

Healthcare

LATEST

1...686970...77Page 69 of 77

TRENDING

EDITORS CHOICE

Is Our Gut a Key to Whether We Get Dementia?

Michael Hunter, MD -
Alzheimer’s dementia is not a normal part of the aging process. Still, the most significant risk factor is increasing age, with most of those with Alzheimer’s disease 65 years and older.

Are Early Morning Laboratory Studies Really Necessary in Hospitalized Patients?

Dr. Hesham A. Hassaballa -
Whenever we get sick with an infection, a very important component of our treatment and recovery plan is sufficient sleep. It allows the body...

The Secrets Of A Twitter Influencer

John Nosta -
Pro tips that help you grab social media attention and build your voice from health innovation theorist John Nosta.

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories